Using Tadalafil to Improve Urinary and Sexual Function After Prostate Surgery
Official title: A Randomized Controlled Trial to Examine the Utility of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Anatomical Endoscopic Enucleation of Prostate (AEEP)
Run by Mansoura University · NCT05955001 · Data updated 2026-11-12
This study is testing if Tadalafil can help men over 40 improve their urinary and sexual function after having prostate surgery for an enlarged prostate.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 1 site (Al Mansurah, Dakahlia Governorate) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | July 2025 |
| Study ends | July 2025 |
| Registry record updated | June 11, 2025 |
| Trial ID | NCT05955001 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are sexually active men aged 40 and older with lower urinary tract symptoms due to BPH who have failed previous medical treatments.
✕Probably not a fit
Patients who are sexually inactive or have severe comorbid conditions such as uncontrolled diabetes or significant renal insufficiency may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the efficacy of Tadalafil, a medication commonly used for erectile dysfunction, in improving lower urinary tract symptoms and erectile function in men who have undergone endoscopic enucleation of the prostate due to benign prostatic hyperplasia (BPH). The study hypothesizes that Tadalafil may alleviate storage symptoms and enhance recovery of erectile function post-surgery. It is a randomized controlled trial comparing Tadalafil to a placebo, focusing on sexually active men aged 40 and older who have not responded to previous medical treatments for BPH. The trial aims to provide insights into the relationship between urinary symptoms and erectile dysfunction following prostate surgery.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for men suffering from erectile dysfunction and urinary symptoms after prostate surgery.
How similar studies have gone: Previous studies have shown mixed results regarding the improvement of erectile function and urinary symptoms after prostate surgery, indicating that this approach may provide new insights but is not entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients' age ≥ 40 years * LUTS secondary to BOO due to BPH who failed medical treatment * International prostate symptom scores (IPSS) \>15 and bother score (QOL) ≥ 3 (according to IPSS question 8) * Peak urinary flow rate (Qmax) \<15 ml/sec. * ASA (American society of anaesthesiologists) score ≤ 3. * Sexually active men, not receiving PDE5I Exclusion Criteria: * Patients using nitrates, potassium channel opener, or α1-blockers doxazosin and terazosin for control of hypertension * Patients with unstable angina pectoris, recent myocardial infarction or stroke myocardial insufficiency. * Patients with severe hepatic or renal insufficiency. * Patients who are sexually inactive. * Patients with uncontrolled diabetes mellitus or neurologic condition(eg. parkinsoism)
Where it's running
-
Urology and Nephrology Center
Al Mansurah, Dakahlia Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Mahmoud Laymon, MD,MRCS — urology and nephrology center mansoura university
- Study coordinator: Mahmoud Laymon, MD,MRCS
- Email: dr_mahmoudlaymon@mans.edu.eg
- Phone: 01002275698
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HIP2602 for Erectile Dysfunction: Testing a new treatment in adults
This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.
-
Platelet-Rich Plasma for Erectile Dysfunction After Prostate Surgery
This trial tests whether injecting a patient’s own platelet-rich plasma can improve erectile function in men who have persistent ED more than a year after nerve-sparing radical prostatectomy.
-
Pudendal artery plaque and erectile dysfunction in men with heart disease
A small study tests whether plaque in the internal pudendal arteries is linked to erectile function in men with coronary artery disease who are undergoing coronary angiography.
-
Piezoelectric Low-Intensity Shockwave Therapy for erectile dysfunction in PDE5i nonresponders
This study tests whether four weeks of low‑intensity, linear piezoelectric shockwave therapy can improve erectile function in men with ED who did not respond to PDE5 inhibitors.
-
Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men
This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.
-
Lifestyle changes to improve erectile function in men with metabolic syndrome
A six-month lifestyle program is being tried to see if it improves erectile function and penile blood flow in men who have erectile dysfunction linked to metabolic syndrome.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.